Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hereditary Sensory and Autonomic Neuropathies × parsaclisib × Myeloid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1 Lymphoid 1

Conditions

Myeloproliferative Disorders 3 Primary Myelofibrosis 2 Lymphoma, Non-Hodgkin 1 Hereditary Sensory and Autonomic Neuropathies 1

Interventions

venetoclax 1 ruxolitinib 1 parsaclisib 1 CA-4948 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02718300 2024-05-01

A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis

Incyte Corporation

Phase 2 Terminated

74 enrolled 40 charts

Myeloproliferative Disorders, Hereditary Sensory and Autonomic Neuropathies, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡